Download PDF
Exp Clin Endocrinol Diabetes 2007; 115(4): 232-239
DOI: 10.1055/s-2007-970576
Article

© J. A. Barth Verlag in Georg Thieme Verlag KG · Stuttgart · New York

The Divergent Effect of Insulin-Like Growth Factor Binding Protein (IGFBP) - 1 on IGF-induced Steroidogenesis in Bovine Adrenocortical Cells is not due to its Phosphorylation Status

C. Fottner 1 , G. Spöttl 2 , M. M. Weber 1
  • 1Schwerpunkt Endokrinologie und Stoffwechselerkrankungen, I. Medizinische Klinik und Poliklinik der Johannes Gutenberg Universität Mainz
  • 2Medizinische Klinik II, Klinikum Grosshadern, Ludwig-Maximilians-Universität München, Germany
Further Information

Publication History

received 30. 7. 2006 final decision 6. 9. 2006

accepted 6. 9. 2006

Publication Date:
03 May 2007 (online)

Also available at
    Permissions and Reprints

Abstract

In previous studies we have shown that insulin-like growth factor (IGF)-II stimulates basal as well as ACTH-induced cortisol secretion from bovine adrenocortical cells more potently than IGF-I. The steroidogenic effect of both, IGF-I and IGF-II, is mediated through the IGF-I receptor and modified by locally produced IGF binding proteins. Further studies demonstrate that bovine adrenocortical cells do synthesize IGFBP-1 to -4 and that their secretion is regulated differentially by IGFs and ACTH. Since IGFBP-1 selectively is induced 3- to 4- fold by ACTH, the aim of the following studies was to evaluate the effect of IGFBP-1 on IGF-induced cortisol secretion from bovine adrenocortical cells in primary culture. Coincubation of bovine adrenocortical cells with purified IGFBP-1 (30 nM) induced a time - and dose-dependent potentiating effect (38±2%) on IGF-I-stimulated (6.5 nM) cortisol-secretion, wheras the IGF-II induced steroidogenic effect was inhibited (40±3%) by IGFBP-1. Similar results were found when bovine adrenocortical cells were preincubated with IGFBP-1 before stimulation experiments with IGFs were performed. In order to evaluate the influence of different phosphorylation states of IGFBP-1 on the steroidogenic effect of IGF-I and IGF-II and on the affinity to IGFs, a highly phosphorylated (pIGFBP-1) and a dephosphorylated isoform (dIGFBP-1) of IGFBP-1 have been separated by anion exchange chromatography for further incubation experiments and binding studies. No different effects on IGF-I or IGF-II-induced steroidogenesis were observed when a highly phosphorylated IGFBP-1 isoform was used, compared to the dephosphorylated IGFBP-1 isoforms. In binding studies IGFBP-1 did show high affinity binding for IGF-I with a calculated association constant (Ka) of 2,17×109 M-1. Similar association constants were calculated for dIGFBP-1 and pIGFBP-1 (1,93×109 M-1 and 2,67×109 M-1 respectively) and no difference in binding capacity was observed when IGF-II was used as ligand. In Conclusion, these results demonstrate that in bovine adrenocortical cells IGFBP-1 time- and dose-dependently inhibits the steroidogenic effect of IGF-II and stimulates the effect of IGF-I. The observed modulatory effect of IGFBP-1 is independent of the mode of incubation and its phosphorylation status. The previously observed stronger steroidogenic potency of IGF-II in bovine adrenocortical cells therefore can not be explained by an interaction with IGFBP-1. The mechanisms by which IGFBP-1 divergently regulates the steroidogenic effect of IGF-I and IGF-II remain unclear at present and further investigation is necessary to elucidate the mechanisms by which IGFBP-1 modulates IGF action in the adult adrenal gland.

Key words

insulin-like growth factor - IGF-I - IGF-II - IGF-binding protein-1 - phosphorylation - adrenal

References

  • 1 Arafah BM. Insulin-like growth factor-I receptors in the rat adrenal.  J Lab Clin Med. 1991;  118 531-537
    PubMedSearch in Google Scholar
  • 2 Bankowski E, Sobolewski K, Palka J, Jaworski S. Decreased expression of the insulin-like growth factor-I-binding protein-1 (IGFBP-1) phosphoisoform in pre-eclamptic Wharton's jelly and its role in the regulation of collagen biosynthesis.  Clin Chem Lab Med. 2004;  42 175-181
    CrossrefPubMedSearch in Google Scholar
  • 3 Bunn RC, Fowlkes JL. Insulin-like growth factor binding protein proteolysis.  Trends Endocrinol Metab. 2003;  14 176-181
    PubMedSearch in Google Scholar
  • 4 Busby WH, Klapper DG, Clemmons DR. Purification of a 31,000-Dalton Insulin-like growth factor binding protein from human amniotic fluid.  J Biol Chem. 1988;  263 14203-14210
    PubMedSearch in Google Scholar
  • 5 Clemmons DR. Role of post translational modifications in modifying the biologic activity of insulin-like growth factor binding proteins. In: LeRoith D, Raiza MK (eds.). Current Directions in Insulin-like growth factor Research. New York, Plenum Press 1994: 245-253
    Search in Google Scholar
  • 6 Conover CA, Clarkson JT, Bale LK. Insulin-like growth factor II enhancement of human fibroblast growth via a non-receptor mediated mechanism.  Endocrinology. 1994;  135 76-82
    CrossrefPubMedSearch in Google Scholar
  • 7 Coverly JA, Baxter RC. Phosphorylation of insulin-like growth factor binding proteins.  Mol Cell Endocrinol. 1997;  128 1-5
    CrossrefPubMedSearch in Google Scholar
  • 8 Ferry RJ, Cerri RW, Cohen P. 1999 Insulin-like growth factor binding proteins: new proteins, new functions.  Horm Res. 1999;  51 53-67
    CrossrefPubMedSearch in Google Scholar
  • 9 Firth SM, Baxter RC. Cellular actions of Insulin-like grpwth factor binding proteins.  Endocrine Rev. 2002;  23 824-854
    CrossrefPubMedSearch in Google Scholar
  • 10 Fottner C, Engelhardt D, Elmlinger MW, Weber MM. Identification and Characterization of Insulin-like growth factor binding protein -expression and -secretion by adult human adrenocortical cells: Regulation by Insulin-like growth factors (IGFs) and adrenocorticotropin (ACTH).  J Endocrino. 2001;  168 465-474
    CrossrefPubMedSearch in Google Scholar
  • 11 Fottner C, Engelhardt D, Weber MM. Regulation of steroidogenesis by Insulin-like growth factors (IGFs) in adult human adrenocortical cells: IGF-I, and more potently IGF-II, preferentially enhance androgen biosynthesis through interaction with the IGF-I receptor and IGF-binding proteins.  J Endocrinol. 1998;  158 409-417
    CrossrefPubMedSearch in Google Scholar
  • 12 Fottner C, Engelhardt D, Weber MM. Characterization of Insulin-like growth factor binding proteins (IGFBPs) secreted by adult bovine adrenocortical cells in primary culture: Regulation by Insulin-like growth factors and Adrenocorticotropin (ACTH).  Horm Metab Res. 1999;  31 203-208
    PubMedSearch in Google Scholar
  • 13 Gibson JM, Aplin JD, White A, Westwood M. Regulation of IGF bioavailability in pregnancy.  Mol Hum Reprod. 2001;  7 79-87
    CrossrefPubMedSearch in Google Scholar
  • 14 Gibson JM, Westwood M, Siddal SK, Shaik T, White A. IGFBP-1 is proteolysed by decidual cell medium, hepG2-medium and amniotic fluid. 4th International Symposium on Insulin-like growth factors, Tokyo 1997: C-06
  • 15 Han VKM, Lu F, Bassett N, Yang KP, Delhanty PJD, Challis JRG. Insulin-like growth factor-II (IGF-II) messenger ribonucleic acid is expressed in steroidogenic cells of the developing ovine adrenal gland: evidence of an autocrine/paracrine role for IGF-II.  Endocrinology. 1992;  131 3100-3109
    CrossrefPubMedSearch in Google Scholar
  • 16 Han VKM, Lund PK, Lee DC, D'Ércole AJ. Expression of somatomedin/insulin-like growth factor messenger RNAs in the human fetus: identification, charaterization and tissue distribution.  J Clin Endocrinol Metab. 1988;  66 422-429
    CrossrefPubMedSearch in Google Scholar
  • 17 Irwin JC, Giudice LC. Insulin-like growth factor binding protein-1 binds to placental cytotrophoblast α5ß1 integrin and inhibits cytotrophoblast invasion into decidualized endometrial stromal cultures.  Growth Horm IGF Res. 1998;  8 21-31
    PubMedSearch in Google Scholar
  • 18 Irwin JC, Suen LF, Faessen GH, Popovici RM, Giudice LC. Insulin-like growth factor (IGF)-II inhibition of endometrial stromal cell tissue inhibitor of metalloproteinase-3 and IGF-binding protein-1 suggests paracrine interactions at the decidua:trophoblast interface during human implantation.  J Clin Endocrinol Metab. 2001;  86 2060-2064
    CrossrefPubMedSearch in Google Scholar
  • 19 Jones LI, Clemmons DR. Insulin-like growth-factors and their Binding proteins: Biological actions.  Endocrine Rev. 1995;  16 3-34
    CrossrefPubMedSearch in Google Scholar
  • 20 Jones LI, D'Ercole AJ, Camacho-Hubner C, Clemmons DR. Phoshorylation of Insulin-like growth factor (IGF)-binding protein 1 in cell culture and in vivo.  Proc Natl Acad Sci USA. 1991;  18 7481-7485
    PubMedSearch in Google Scholar
  • 21 Jyung RW, Mustoe JA, Busby Jr WH, Clemmons DR.. Increased wound-breaking strength induced by insulin-like growth factor I in combination with insulin-like growth factor binding protein-1.  Surgery. 1994;  115 223-229
    PubMedSearch in Google Scholar
  • 22 Koistinen R, Angervo M, Leinonen P, Hakala T, Seppälä M. Phosphorylation of insulin-like growth factor bindin protein-1 increases in human amniotic fluid and decidua from early to late pregnancy.  Clin Chem Acta. 1993;  215 189-199
    CrossrefPubMedSearch in Google Scholar
  • 23 Kratz G, Lake M, Ljungström K, Forsberg G, Haegerstrand , Gidlund M. 1992 Effect of recombinant IGF binding protein-1 on primary cultures of human keratinocytes and fibroblasts: selective enhancement of IGF-i but not IGF-II-induced cell proliferation.  Exp Cell Res. 1992;  201 381-385
    PubMedSearch in Google Scholar
  • 24 Lang CH, Vary TC, Frost RA.. Acute in vivo elevation of insulin-like growth factor (IGF) binding protein-1 decreases plasma free IGF-I and muscle protein synthesis.  Endocrinology. 2003;  144 3922-3933
    CrossrefPubMedSearch in Google Scholar
  • 25 Lee PDK, Conover CA, Powell RD. Regulation and function of insulin-like growth factor binding protein-1.  Proc Soc Exp Biol Med. 1993;  204 4-29
    PubMedSearch in Google Scholar
  • 26 Lee PDK, Giudice LC, Conover CA, Powell DR. Insulin-like growth factor binding protein-1 - Recent findings and new directions.  Proc Soc Exp Biol Med. 1997;  216 319-357
    CrossrefPubMedSearch in Google Scholar
  • 27 Maile LA, Holly JMP. Insulin-like growth factor binding protein (IGFBP) proteolysis: occurrence, identification, role and regulation.  Growth Horm & IGF Res. 1999;  9 85-95
    PubMedSearch in Google Scholar
  • 28 Mesiano S, Mellon SH, Jaffe RB. Mitogenic action, regulation, and localization of insulin-like growth factors in the human fetal adrenal gland.  J Clin Endocrinol Metab. 1993;  76 968-975
    CrossrefPubMedSearch in Google Scholar
  • 29 Naaman E, Chatelain P, Saez JM, Durand P. In vitro effect of insulin and insulin-like growth factor-I on cell multiplication and adrenocorticotropin responsiveness of fetal adrenal cells.  Biol Reprod. 1989;  40 570-577
    PubMedSearch in Google Scholar
  • 30 Nakamura M, Miyamoto S, Maeda H, Ishii G, Hasebe T, Chiba T, Asaka M, Ochiai A. Matrix metalloproteinase-7 degrades all insulin-like growth factor binding proteins and facilitates insulin-like growth factor bioavailability.  Biochem Biophys Res Commun. 2005;  333 1011-1016
    CrossrefPubMedSearch in Google Scholar
  • 31 Penhoat A, Chatelain PG, Jaillard C, Saez JM. Characterization of insulin-like growth factor I and insulin receptors on cultured bovine adrenal fasciculata cells. Role of these peptides on adrenal cell function.  Endocrinology. 1988;  122 2518-2526
    PubMedSearch in Google Scholar
  • 32 Penhoat A, Jaillard C, Saez JM. Synergistic effects of corticotropin and insulin-like growth factor I on corticotropin receptors and corticotropin responsiveness in cultured bovine adrenocortical cells.  Biochem Biophys Res Commun. 1989;  165 355-359
    CrossrefPubMedSearch in Google Scholar
  • 33 Peterkofsky B, Gosiewska A, Wilson S, Kim YR. Phosphorylation of rat insulin-like growth factor binding protein-1 does bot affect its biological properties.  Arch Biochem Biophys. 1998;  357 101-110
    CrossrefPubMedSearch in Google Scholar
  • 34 Pham-Huu-Trung MT, Villette JM, Bogyo A, Duclos JM, Fiet J, Binoux M. Effects of insulin-like growth factor-I (IGF-I) on enzymatic activity in human adrenocortical cells: Interactions with ACTH.  J Steroid Biochem Mol Biol. 1991;  39 903-909
    PubMedSearch in Google Scholar
  • 35 Siddals KW, Westwood M, Gibson JM, White A. IGF-binding protein-1 inhibits IGF effects on adipocyte function: implications for insulin-like actions at the adipocyte.  J Endocrinol. 2002;  174 289-297
    CrossrefPubMedSearch in Google Scholar
  • 36 Weber MM, Auernhammer CJ, Kiess W, Engelhardt D. Insulin-like growth factor receptors in normal and tumorous adult human adrenocortical glands.  Eur J Endocrinol. 1997;  136 296-303
    CrossrefPubMedSearch in Google Scholar
  • 37 Weber MM, Fottner C, Engelhardt D. Adrenocortical and adrenomedullary cells. In: Endocrine Cell Culture, Ed.: S. Bidey, Cambridge University Press 1998: 75-93
    Search in Google Scholar
  • 38 Weber MM, Kiess W, Beikler T, Simmler P, Reichel M, Adelmann B, Kessler U, Engelhardt D. Identification and characterization of insulin-like growth factor I (IGF-I) and IGF-II/mannose-6-phosphate (IGF-II/M6P) receptors in bovine adrenal cells.  Eur J Endocrinol. 1994;  130 265-270
    PubMedSearch in Google Scholar
  • 39 Weber MM, Simmler P, Fottner C, Engelhardt D. Insulin-like growth factor II (IGF-II) is more potent than IGF-I in stimulating cortisol secretion from cultured bovine adrenocortical cells: Interaction with the IGF-I receptor and IGF-binding proteins.  Endocrinology. 1995;  136 3714-3720
    CrossrefPubMedSearch in Google Scholar
  • 40 Westwood M, Gibson JM, White A. Purification and characterization of the Insulin-like growth factor-binding protein-1 phosphoform found in normal plasma.  Endocrinology. 1997;  138 1130-1136
    CrossrefPubMedSearch in Google Scholar
  • 41 Westwood M, Gibson JM, Williams AC, Clayton PE, Hamberg O, Flyvbjerg A, White A. Hormonal regulation of circulating insulin-luke growth factor binding protein-1 phosphorylation status.  J Clin Endocrinol Metab. 1995;  80 3520-3527
    CrossrefPubMedSearch in Google Scholar

1 Supported by DFG Grant WE 1356/4-2 (to M.M.W.)

Correspondence

C. Fottner

Schwerpunkt Endokrinologie und Stoffwechselerkrankungen

I. Medizinische Klinik und Poliklinik

Johannes Gutenberg Universität Mainz

Langenbeckstrasse 1

55131 Mainz

Germany

Phone: +49/61/31 17 72 60

Fax: +49/061/31 17 56 08

Email: fottner@endokrinologie.klinik.uni-mainz.de